[ad_1]
DUBLIN – (Business Wire) – The "Glioblastoma
Multiforme (GBM) – Revision of the pipeline, S1 2018 " drug pipelines
been added to ResearchAndMarkets.com & # 39; s offer.
Glioblastoma Multiforme (GBM) – Pipeline Revision, S1 2018,
provides comprehensive information on treatments under development
Glioblastoma multiforme (GBM) (oncology), with badysis by
stage of development, drug target, mechanism of action, route of
administration (RoA) and type of molecule.
The guide covers the descriptive pharmacological action of the drug.
its comprehensive history of research and development and its latest
news and press releases.
The Glioblastoma Multiforme (GBM) pipeline guide (Oncology) also reviews
of the main actors involved in the therapeutic development of glioblastoma
Multiforme (GBM) and includes dormant and abandoned projects.
The guide covers treatments under development by
Companies / Universities / Institutes, molecules developed by companies
in phase III, phase II, phase I, phase 0, deposition by IND / CTA, preclinical,
Discovery and Unknown steps are 10, 108, 67, 1, 9, 160, 28 and 6
respectively. Similarly, the portfolio of universities in phase III, phase
Phases II, Phase I, Phase 0, Preclinical and Discovery comprise 1, 11,
15, 1, 43 and 10 molecules, respectively.
Glioblastoma Multiforme (GBM) (Oncology) pipeline guide helps in
identify and monitor emerging market players and their
portfolios, improves decision-making capabilities and helps to create
effective control strategies to gain a competitive advantage.
Featured Companies
-
AbbVie Inc
-
Actuate Therapeutics Inc
-
APIM Therapeutics AS
-
Boehringer Ingelheim GmbH
-
Boston Biomedical Inc
-
Bristol-Myers Squibb Co
-
Caladrius Biosciences Inc
-
Celldex Therapeutic Inc
-
DNAtrix Inc
-
Dr. Reddy's Laboratories Ltd
-
Therapeutic Ecrins SAS
-
Eisai Co Ltd
-
Eli Lilly and Co.
-
F-star Biotechnology Ltd
-
Hamlet Pharma AB
-
ImmunoCellular Therapeutics Ltd
-
Immunomedics Inc
-
Johnson & Johnson
-
Juno Therapeutic Inc
-
Kadmon Corp LLC
-
Kancera AB
-
Merck KGaA
-
MetaMax Ltd
-
Midatech Pharma Plc
-
Therapeutics Oncternal Inc
-
Therapeutic Peloton Inc.
-
Peptomyc SL
-
Pfizer Inc
-
ReNeuron Group Plc
-
Rgenix Inc
-
Richter Gedeon Nyrt
-
Sanofi
-
Taiho Pharmaceutical Co Ltd
-
Therapeutic Terpenoid Inc
-
and many, many more …
For more information on this report on drug pipelines, visit https://www.researchandmarkets.com/research/g2rdqc/glioblastoma?w=4.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20181019005178/fr/
ResearchAndMarkets.com
Laura Wood, Senior Director
[email protected]
For
E.S.T Office Hours: 1-917-300-0470
For a toll-free call to the United States and Canada
1-800-526-8630
For GMT office hours, call + 353-1-416-8900
Related
Topics: Brain
Drugs against cancer
[ad_2]
Source link
